Results 31 to 40 of about 677,058 (306)

Recurrence after ESD curative resection for early gastric cancer

open access: yesSurgical Case Reports, 2021
Background Endoscopic submucosal dissection (ESD) is gaining ground as a minimally invasive treatment for early gastric cancer (EGC) that has a negligible risk of lymph node metastasis.
Ayako Kamiya   +12 more
doaj   +1 more source

Modeling of influential predictors of gastric cancer incidence rates in Golestan Province, North Iran [PDF]

open access: yes, 2014
Golestan province has a reputation for relatively high incidence rates of gastric cancer in Iran. Along with dietary, lifestyle and environmental influential factors, soil selenium and high levels of pesticide used may exert influence in this region. The
Behnampour, N.   +3 more
core   +1 more source

Is the Reinitiation of Antiplatelet Agents Safe at 1 Week after Gastric Endoscopic Submucosal Dissection? Assessment of Bleeding Risk Using the Forrest Classification

open access: yesGut and Liver, 2017
Background/AimsDelayed bleeding after gastric endoscopic submucosal dissection (ESD) commonly occurs within 3 days, but it may also occur after 1 week following ESD, especially in antiplatelet agent users.
Jong Yeul Lee   +4 more
doaj   +1 more source

Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells

open access: yesMedComm, 2023
Drug resistance remains the greatest challenge in improving outcomes for cancer patients who receive chemotherapy and targeted therapy. Surmounting evidence suggests that a subpopulation of cancer cells could escape intense selective drug treatment by ...
Xiaohai Song   +13 more
doaj   +1 more source

Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion [PDF]

open access: yes, 2017
Thousands of genes have been well demonstrated to play important roles in cancer progression. As genes do not function in isolation, they can be grouped into “networks” based on their interactions.
Chen, Xiao-wan   +9 more
core   +2 more sources

GASTRIC CANCER [PDF]

open access: yesSouthern Medical Journal, 1917
n ...
openaire   +2 more sources

Gastric Microbiome and Gastric Cancer [PDF]

open access: yesThe Cancer Journal, 2014
Cancer of the stomach is the fourth most common cancer worldwide. The single strongest risk factor for gastric cancer is Helicobacter pylori-associated chronic gastric inflammation. Among persons with H. pylori infection, strain-specific components, host immune responses, and environmental factors influence the risk for gastric disease, including ...
Kyle M, Brawner   +2 more
openaire   +2 more sources

The role of gastric microbiota in gastric cancer [PDF]

open access: yesGut Microbes, 2020
Gastric cancer represents one of the leading causes of cancer deaths worldwide. Helicobacter pylori (H. pylori) infection is the strongest risk factor associated with gastric cancer. Due to new molecular techniques allowing greater identification of stomach microbes, investigators are beginning to examine the role that bacteria other than H.
Oliver A. Stewart, Fen Wu, Yu Chen
openaire   +3 more sources

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial

open access: yesBMC Gastroenterology, 2021
Background This randomized, open-label trial aimed to compare the efficacy of 10-day bismuth-containing quadruple therapy (BQT) with 7-day proton-pump inhibitor-clarithromycin containing standard triple therapy (STT) as an empirical first-line ...
Young-Il Kim   +5 more
doaj   +1 more source

Gastric cancer. [PDF]

open access: yesBMJ, 1992
Summary We are gaining a clearer insight into the causes and mechanisms of gastric carcinogenesis, and may be able to reduce the incidence in the future by Helicobacter pylori eradication, perhaps in conjunction with nutritional supplements.
openaire   +5 more sources

Home - About - Disclaimer - Privacy